Listed company Liminatus Pharma plans to raise $500 million to invest in BNB
2025/07/28 19:47
PANews reported on July 28 that according to Businessinsider, preclinical biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) announced today that it plans to strategically expand into the cryptocurrency and blockchain fields. The company plans to establish a subsidiary called "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to raise and deploy up to US$500 million in phases, with the goal of making strategic long-term investments in BNB.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
The Next Virtuals? Explaining the Narrative Flywheel Behind Zora’s 1,000% Surprise
Author: dpycm Translated by: Tim, PANews PANews Note: The content of the article is only the author's personal opinion, not investment advice, DYOR. I believe everyone must have experienced the
Share
PANews2025/07/28 16:18
Dow Jones down, S&P near records as markets focus on U.S.-China talks
U.S. stocks are mixed as initial enthusiasm over the U.S.-EU trade deal died down.
Share
Crypto.news2025/07/29 02:12
JPMorgan Chase: Raises Coinbase's Target Price from $215 to $404
PANews July 28 news, JPMorgan Chase: Raised Coinbase (COIN.O) target price from $215 to $404.
Share
PANews2025/07/28 12:39